Exelon (NASDAQ:EXC – Get Free Report) had its price target hoisted by analysts at Scotiabank from $42.00 to $44.00 in a research report issued on Thursday,Benzinga reports. The firm currently has a “sector perform” rating on the stock. Scotiabank’s target price points to a potential upside of 2.01% from the stock’s current price.
EXC has been the subject of a number of other reports. Evercore ISI upgraded Exelon from an “in-line” rating to an “outperform” rating and upped their target price for the company from $43.00 to $44.00 in a research report on Tuesday, January 21st. Barclays dropped their price objective on Exelon from $44.00 to $42.00 and set an “overweight” rating for the company in a research report on Wednesday, January 22nd. Guggenheim upgraded Exelon from a “neutral” rating to a “buy” rating in a research report on Thursday, January 23rd. Finally, Morgan Stanley dropped their price objective on Exelon from $46.00 to $44.00 and set an “equal weight” rating for the company in a research report on Friday, November 22nd. Five equities research analysts have rated the stock with a hold rating and five have given a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and a consensus price target of $43.38.
Check Out Our Latest Analysis on Exelon
Exelon Stock Up 0.6 %
Exelon (NASDAQ:EXC – Get Free Report) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.64 EPS for the quarter, beating analysts’ consensus estimates of $0.59 by $0.05. Exelon had a return on equity of 9.47% and a net margin of 10.60%. During the same period last year, the business posted $0.60 EPS. As a group, research analysts forecast that Exelon will post 2.46 EPS for the current fiscal year.
Insider Buying and Selling at Exelon
In other Exelon news, EVP Colette D. Honorable sold 1,463 shares of the stock in a transaction dated Monday, February 3rd. The stock was sold at an average price of $40.57, for a total value of $59,353.91. Following the completion of the transaction, the executive vice president now directly owns 2,271 shares in the company, valued at approximately $92,134.47. This trade represents a 39.18 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Corporate insiders own 0.10% of the company’s stock.
Institutional Investors Weigh In On Exelon
Several institutional investors and hedge funds have recently made changes to their positions in EXC. Norges Bank acquired a new stake in shares of Exelon in the fourth quarter valued at about $479,597,000. FMR LLC lifted its holdings in shares of Exelon by 46.9% in the fourth quarter. FMR LLC now owns 17,306,652 shares of the company’s stock valued at $651,422,000 after purchasing an additional 5,524,103 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Exelon by 109.0% during the third quarter. JPMorgan Chase & Co. now owns 5,884,282 shares of the company’s stock worth $238,608,000 after acquiring an additional 3,068,309 shares during the period. Vanguard Group Inc. grew its stake in shares of Exelon by 2.5% during the 4th quarter. Vanguard Group Inc. now owns 127,335,351 shares of the company’s stock worth $4,792,903,000 after acquiring an additional 3,064,673 shares during the period. Finally, Invesco Ltd. increased its stake in shares of Exelon by 25.8% in the fourth quarter. Invesco Ltd. now owns 13,718,745 shares of the company’s stock worth $516,374,000 after purchasing an additional 2,817,174 shares in the last quarter. Institutional investors and hedge funds own 80.92% of the company’s stock.
About Exelon
Exelon Corporation, a utility services holding company, engages in the energy distribution and transmission businesses in the United States and Canada. The company is involved in the purchase and regulated retail sale of electricity and natural gas, transmission and distribution of electricity, and distribution of natural gas to retail customers.
See Also
- Five stocks we like better than Exelon
- Natural Gas Prices Continue To Rally, These Stocks Should Benefit
- Archer Aviation Lands BlackRock Investment—What’s Next for ACHR?
- Insider Trades May Not Tell You What You Think
- Buffett Buys More Occidental Petroleum—Sticking to His Playbook
- What is the Dogs of the Dow Strategy? Overview and Examples
- CVS Health: Earnings Beat Ignites Stock Rally
Receive News & Ratings for Exelon Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Exelon and related companies with MarketBeat.com's FREE daily email newsletter.